Study Stopped
Recruitment stalled. Study terminated before inclusion of sufficient number of participants included
The Benefit of Arthroscopic Partial Meniscectomy in Middle-Aged Patients
SLAMSHAM
1 other identifier
interventional
41
1 country
2
Brief Summary
BACKGROUND Osteoarthritis (OA) is the most common form of arthritis and the knee is one of the most affected joints. The meniscus plays an important role in the development of knee OA. It is unclear whether a degenerative meniscus tear is a risk factor in developing knee OA or a sign of the disease. The standard treatment for a degenerative meniscus tear is an arthroscopic partial meniscectomy (APM). There is strong evidence that this puts the knee at high risk of later developing OA. Earlier studies have shown a significant placebo effect from surgical procedures, in general, and an arthroscopic knee procedure, in particular. PURPOSE The overall purpose of this study is to gather information that might lead to a reduction in the development of OA in middle-aged patients. The investigators hypothesise that the benefit from an arthroscopic partial meniscectomy is due to the placebo effect measured on self-reported outcomes, and that the meniscectomy contributes to the development of knee OA as seen on radiography. METHODS The investigators will include 100 patients aged from 35 to 55 years with an MRI-confirmed medial meniscus tear and without knee OA (excluding patients with Grade 3 or 4 knee OA on the Kellgren-Lawrence classification). Participants will be randomised to either a standard APM procedure or a sham procedure and both groups will receive standard post-operative care. The primary outcomes will be a self-reported questionnaire, the KOOS score, and a functionality test after 3 and 24 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2011
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2010
CompletedFirst Posted
Study publicly available on registry
December 22, 2010
CompletedStudy Start
First participant enrolled
February 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedOctober 24, 2017
October 1, 2017
4.7 years
December 21, 2010
October 23, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Knee injury and Osteoarthritis Outcome Score - KOOS
The primary outcome at 2 years follow-up will be a self-reported questionnaire, the Knee injury and Osteoarthritis Outcome Score (KOOS), comprising five different subscales: 1. pain 2. other symptoms 3. activities in daily living (ADL) 4. function in sport and recreation 5. knee-related quality of life (QOL) A mean of the 5 subscales will be calculated (KOOS5 = \[KOOSpain + KOOSsymptoms + KOOSADL + KOOSsport\&rec KOOSQOL\] / 5. Range 0 to 100, worst to best)
2 year follow-up
Secondary Outcomes (6)
One-leg jump test
2 year follow-up
Knee-bending test
2 year follow-up
Knee extension strength
2 year follow-up
EQ-5D
2 year follow-up
SF-36
2 year follow-up
- +1 more secondary outcomes
Study Arms (2)
APM group
EXPERIMENTALSham group
PLACEBO COMPARATORInterventions
The arthroscopic partial meniscectomy will be performed on an outpatient basis by experienced surgeons at a level of at least attending physicians or at the last year of residency. All arthroscopies will be performed in general anaesthesia combined with local anaesthesia. After general anaesthesia is induced, the knee will be examined for stability. Thereafter two standard portals on the lateral and medial side of the ligamentum patella will be created but no outflow cannula inserted. An arthroscope will be used with a pressure-controlled irrigation system. Tourniquet use will be according to surgeon preference. The strategy for the meniscectomy will be to preserve as much tissue as possible. A standard operation protocol will be used to document possible findings in cartilage, ligaments, synovium and the medial and lateral meniscus. Meniscus lesions and type of will be registered and changes in the articular cartilage will be classified according to the ICRS classification
The placebo procedure will be performed under the same conditions as above. The patient will be fully sedated in general anaesthesia. As above, the stability of the knee will be examined. Local anaesthetic will be applied as above and 2 skin incisions will be made at the same location and the same size as above. Then the knee will be manipulated as if a real arthroscopy were being done, the spillage of water and all the other equipment needed for an arthroscopy will be used and manipulated. No instruments will enter the portals for arthroscopy to avoid the possibility of osteochondral lesions and unwanted interventions by the surgeon.
Eligibility Criteria
You may qualify if:
- Patients with knee pain for more than 2 months without significant trauma (only the index knee will be included)
- MRI-confirmed medial meniscus lesion (patients with a medial meniscus lesion AND a lateral lesion will also be included)
- Age 35-55 years\*
- Eligible for outpatient surgery - ASA score 1-2
You may not qualify if:
- Patients in need of acute surgery e.g. locking knees, high-energy trauma
- Symptoms associated with other musculoskeletal co-morbidities overriding the symptoms of the knee
- Grade 3 or 4 knee OA on the Kellgren-Lawrence classification
- Knee surgery within the last 2 years
- Obese patients with BMI \> 35
- Patients with ischemic heart disease
- Patients with diabetic late-complications
- Patients with thrombophilia
- Pregnancy
- Patients unable to speak Danish
- Patients with drug or alcohol abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Slagelse Hospitallead
- University of Southern Denmarkcollaborator
Study Sites (2)
Næstved Hospital
Næstved, Region Sjælland, 4800, Denmark
Slagelse Hospital
Slagelse, Region Sjælland, 4200, Denmark
Related Publications (3)
Roos EM, Hare KB, Nielsen SM, Christensen R, Lohmander LS. Better outcome from arthroscopic partial meniscectomy than skin incisions only? A sham-controlled randomised trial in patients aged 35-55 years with knee pain and an MRI-verified meniscal tear. BMJ Open. 2018 Feb 2;8(2):e019461. doi: 10.1136/bmjopen-2017-019461.
PMID: 29420232DERIVEDHare KB, Lohmander LS, Roos EM. The challenge of recruiting patients into a placebo-controlled surgical trial. Trials. 2014 May 13;15:167. doi: 10.1186/1745-6215-15-167.
PMID: 24884948DERIVEDHare KB, Lohmander LS, Christensen R, Roos EM. Arthroscopic partial meniscectomy in middle-aged patients with mild or no knee osteoarthritis: a protocol for a double-blind, randomized sham-controlled multi-centre trial. BMC Musculoskelet Disord. 2013 Feb 25;14:71. doi: 10.1186/1471-2474-14-71.
PMID: 23442554DERIVED
Study Officials
- STUDY CHAIR
Ewa Roos, Professor
Research Unit of Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense
- PRINCIPAL INVESTIGATOR
Kristoffer B Hare, MD
Dept. of Orthopadeics, Slagelse Hospital, Region Zealand
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
December 21, 2010
First Posted
December 22, 2010
Study Start
February 21, 2011
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
October 24, 2017
Record last verified: 2017-10